SNB-011

N/A

Report date: 2025/04/07 16:50:48
NME

Base Information

Drug NameSNB-011
Drug Alias NamePentarlandirPentarlandir UPPTA (Ultrapure and Potent Tannic Acid)AirnecfluPentarlandir UPPTASNB-01 +[6] 
ClassificationSmall molecules
Mechanisms of ActionChymase inhibitorsSARS-CoV-2-3C-like-proteinase inhibitorsD-amino-acid oxidase inhibitors +[7] 
TargetsChymaseSARS-CoV-2-3C-like-proteinaseD-amino-acid oxidase +[5] 
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyneurx International (Taiwan) Corp
China Registration ClassN/A

Develop Information

Active CompaniesSyneurx International (Taiwan) Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A